Third-generation α 1-adrenergic antagonists are pharmacologically uroselective in that they are competitive antagonists for prostatic α 1A-receptors. [16,17] Blockade of these receptors relaxes ...

The daily cost of oxybutynin XL was set at £0.82 (10mg once per day), while for tolterodine IR, it was £1.04 (2mg twice per day). The assumption was made that patients were either fully ...